Effects of quercetin studied in colonic HT-29/B6 cells and rat intestine in vitro

Annals of the New York Academy of Sciences

Volumn 1258, Issue 1, 2012, Pages 100-107

  Amasheh, Maren ^a   Luettig, Julia ^a   Amasheh, Salah ^a   Zeitz, Martin ^a   Fromm, Michael ^a   Schulzke, Jörg Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Barrier function; Claudins; Flavonoid; Tight junction; TNF

Indexed keywords

CELL PROTEIN; CLAUDIN 2; GAMMA INTERFERON; QUERCETIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; COLON MUCOSA; CONTROLLED STUDY; DESCENDING COLON; ELECTROPHYSIOLOGY; EPITHELIUM CELL; HUMAN; HUMAN CELL; ILEUM; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TIGHT JUNCTION; WESTERN BLOTTING;

RATTUS;

EID: 84862887727     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06609.x     Document Type: Article

References (35)

1. Amasheh, M., S. Schlichter, S. Amasheh, et al 2008. Quercetin enhances epithelial barrier function and increases claudin-4 expression in Caco-2 cells. J. Nutr. 138: 1067-1073.
2. Suzuki, T. & H. Hara 2009. Quercetin enhances intestinal barrier function through the assembly of zonula occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J. Nutr. 139: 965-974.
3. Murota, K. & J. Terao 2003. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism. Arch. Biochem. Biophys. 417: 12-17.
4. Shimoi, K., Yoshizumi T. Kido, et al 2003. Absorption and urinary excretion of quercetin, rutin, and alphaG-rutin, a water soluble flavonoid, in rats. J. Agric. Food Chem. 51: 2785-2789.
5. Hertog, M.G.L., P.C.H. Hollman & M.B. Katan 1992. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J. Agric. Food Chem. 40: 2379-2383.
6. Hollman, P.C.A. & I.C.W. Arts 2000. Flavonoids, flavones and flavanols-nature, occurrence and dietary burden. J. Sci. Food Agric. 80: 1081-1093.
7. Middleton, E., C. Kandaswami & T. Theoharides 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 52: 673-751.
8. Zeissig, S., N. Buergel, D. Guenzel, et al 2007. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56: 61-72.
9. Gitter, A.H., F. Wullstein, M. Fromm & J.D. Schulzke 2001. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology 121: 1320-1328.
10. Suenaert, P., V. Bulteel, L. Lemmens, et al 2002. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am. J. Gastroenterol. 97: 2000-2004.
11. Amasheh, M., A. Fromm, S.M. Krug, et al 2010. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J. Cell Sci. 123: 4145-4155.
12. Bruewer, M., A. Luegering, T. Kucharzik, et al 2003. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immunol. 171: 6164-6172.
13. Prasad, S., R. Mingrino, K. Kaukinen, et al 2005. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab. Invest. 85: 1139-1162.
14. Gitter, A.H., K. Bendfeldt, J.D. Schulzke & M. Fromm 2000. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis. FASEB J. 14: 1749-1753.
15. Brandtzaeg, P. 2011. The gut as communicator between environment and host: immunological consequences. Eur. J. Pharmacol. 668(Suppl. 1): S16-S32.
16. Tixier, E., J.P. Galmiche & M. Neunlist 2006. Intestinal neuro-epithelial interactions modulate neuronal chemokines production. Biochem. Biophys. Res. Commun. 344: 554-561.
17. Hausmann, M. & G. Rogler 2008. Immune-non immune networks in intestinal inflammation. Curr. Drug Targets 9: 388-394.
18. Amasheh, M., I. Grotjohann, S. Amasheh, et al 2009. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand. J. Gastroenterol. 44: 1226-1235.
19. - secretion in epithelial monolayers of mucus-forming human colon cells (HT-29/B6). Am. J. Physiol. 261: C574-C582.
20. Amasheh, S., N. Meiri, A.H. Gitter, et al 2002. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J. Cell Sci. 115: 4969-4976.
21. Watson, J.L., S. Ansari, H. Cameron, et al 2004. Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G954-G961.
22. Suzuki, T., S. Tanabe & H. Hara 2011. Kaempferol enhances intestinal barrier function through the cytoskeletal association and expression of tight junction proteins in Caco-2 cells. J. Nutr. 141: 87-94.
23. Atkinson, K.J. & R.K. Rao 2001. Role of protein tyrosine phosphorylation in acetaldehyde-induced disruption of epithelial tight junctions. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G1280-G1288.
24. Jobin, C., S. Haskill, L. Mayer, et al 1997. Evidence for altered regulation of IκBα degradation in human colonic epithelial cells. J. Immunol. 158: 226-234.
25. Ma, T.Y., G.K. Iwamoto, N.T. Hoa, et al 2004. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G367-G376.
26. Schmitz, H., M. Fromm, C.J. Bentzel, et al 1999. Tumor necrosis factor-alpha (TNFalpha) regulates the epithelial barrier in the human intestinal cell line HT-29/6B. J. Cell Sci. 112: 137-146.
27. Wenzel, U., A. Herzog, S. Kuntz & H. Daniel 2004. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics 4: 2160-2174.
28. Chen, Y.C., S.C. Shen, J.M. Chow, et al 2004. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int. J. Oncol. 25: 661-70.
29. Wenzel, U. & H. Daniel 2004. Early and late apoptosis events in human transformed and non-transformed colonocytes are independent on intracellular acidification. Cell Physiol. Biochem. 14: 65-76.
30. Bojarski, C., A.H. Gitter, K. Bendfeldt, et al 2001. Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J. Physiol. 535: 541-52.
31. Camuesco, D., M. Comalada, M.E. Rodriguez-Cabezas, et al 2004. The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br. J. Pharmacol. 143: 908-918.
32. Comalada, M., D. Camuesco, S. Sierra, et al 2005. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-κB pathway. Eur. J. Immunol. 35: 584-592.
33. Nusrat, A. 2000. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279: G851-G857.
34. Heller, F., P. Florian, C. Bojarski, et al 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564.
35. Mankertz, J., S. Tavalali, H. Schmitz, et al 2000. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J. Cell Sci. 113: 2085-2090.